Literature DB >> 18941204

Unique receptor repertoire in mouse uterine NK cells.

Hakim Yadi1, Shannon Burke, Zofia Madeja, Myriam Hemberger, Ashley Moffett, Francesco Colucci.   

Abstract

Uterine NK (uNK) cells are a prominent feature of the uterine mucosa and regulate placentation. NK cell activity is regulated by a balance of activating and inhibitory receptors, however the receptor repertoire of mouse uNK cells is unknown. We describe herein two distinct subsets of CD3(-)CD122(+) NK cells in the mouse uterus (comprising decidua and mesometrial lymphoid aggregate of pregnancy) at mid-gestation: a small subset indistinguishable from peripheral NK cells, and a larger subset that expresses NKp46 and Ly49 receptors, but not NK1.1 or DX5. This larger subset reacts with Dolichus biflores agglutinin, a marker of uNK cells in the mouse, and is adjacent to the invading trophoblast. By multiparametric analysis we show that the phenotype of uNK cells is unique and unprecedented in terms of adhesion, activation, and MHC binding potential. Thus, the Ly49 repertoire and the expression of other differentiation markers strikingly distinguish uNK cells from peripheral NK cells, suggesting that a selection process shapes the receptor repertoire of mouse uNK cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941204     DOI: 10.4049/jimmunol.181.9.6140

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  Resident peritoneal NK cells.

Authors:  Rosemary Gonzaga; Polly Matzinger; Ainhoa Perez-Diez
Journal:  J Immunol       Date:  2011-11-11       Impact factor: 5.422

2.  Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection.

Authors:  Hailong Guo; David J Topham
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

3.  p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease.

Authors:  Aurore Saudemont; Fabien Garçon; Hakim Yadi; Marta Roche-Molina; Nayoung Kim; Anne Segonds-Pichon; Alfonso Martín-Fontecha; Klaus Okkenhaug; Francesco Colucci
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

Review 4.  NK cell trafficking in health and autoimmunity:a comprehensive review.

Authors:  Hui Peng; Zhigang Tian
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

5.  Ly49 receptors activate angiogenic mouse DBA⁺ uterine natural killer cells.

Authors:  Patricia D A Lima; Megan M Tu; Mir Munir A Rahim; Annie R Peng; B Anne Croy; Andrew P Makrigiannis
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

Review 6.  Leukocyte driven-decidual angiogenesis in early pregnancy.

Authors:  Patricia D A Lima; Jianhong Zhang; Caroline Dunk; Stephen J Lye; B Anne Croy
Journal:  Cell Mol Immunol       Date:  2014-07-28       Impact factor: 11.530

7.  In vivo generation of decidual natural killer cells from resident hematopoietic progenitors.

Authors:  Laura Chiossone; Paola Vacca; Paola Orecchia; Daniele Croxatto; Patrizia Damonte; Simonetta Astigiano; Ottavia Barbieri; Cristina Bottino; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Haematologica       Date:  2013-10-31       Impact factor: 9.941

Review 8.  Natural killer cells and regulatory T cells in early pregnancy loss.

Authors:  Surendra Sharma
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

9.  Reduced stathmin-1 expression in natural killer cells associated with spontaneous abortion.

Authors:  Yi Lin; Cui Li; Bin Shan; Wenjing Wang; Shigeru Saito; Jiehan Xu; Jingfang Di; Yanmin Zhong; Da-Jin Li
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

10.  NKG2D blockade inhibits poly(I:C)-triggered fetal loss in wild type but not in IL-10-/- mice.

Authors:  Jessica E Thaxton; Tania Nevers; Eliana O Lippe; Sandra M Blois; Shigeru Saito; Surendra Sharma
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.